IL6 and its interacting partners CXCL2 and CHRDL1 are down-regulated; while other interacting partners UBE2C, SPP1, CP, GOLM1 are up-regulated in the NSCLC network. Here, CXCL2 is linked to non-small cell lung carcinoma.